Literature DB >> 3102831

Long-term effects of nifedipine on plasma levels of 25 hydroxyvitamin D and 1,25 dihydroxyvitamin D in hypertensive hemodialyzed patients.

W Riegel, W H Hörl, A Heidland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3102831     DOI: 10.1007/bf01785712

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  6 in total

1.  1,25 Dihydroxyvitamin D increases hepatocyte cytosolic calcium levels. A potential regulator of vitamin D-25-hydroxylase.

Authors:  D T Baran; M L Milne
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

2.  Verapamil improves defective intestinal calcium absorption in uremia.

Authors:  M S Goligorsky; C Chaimovitz; S Shany; J Rapoport; Y Sharony
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

3.  1,25 dihydroxyvitamin D-induced inhibition of 3H-25 hydroxyvitamin D production by the rachitic rat liver in vitro.

Authors:  D T Baran; M L Milne
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

4.  Long-term effects of nifedipine on carbohydrate and lipid metabolism in hypertensive hemodialyzed patients.

Authors:  W Riegel; W H Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1986-10-31

Review 5.  Renin, calcium metabolism and the pathophysiologic basis of antihypertensive therapy.

Authors:  L M Resnick; J H Laragh
Journal:  Am J Cardiol       Date:  1985-12-06       Impact factor: 2.778

6.  A sensitive and simplified radioimmunoassay for 1,25-dihydroxyvitamin D3.

Authors:  S Scharla; H Schmidt-Gayk; H Reichel; E Mayer
Journal:  Clin Chim Acta       Date:  1984-10-15       Impact factor: 3.786

  6 in total
  1 in total

Review 1.  The association between drugs frequently used by the elderly and vitamin D blood levels: a review of observational and experimental studies.

Authors:  Anne Claire B van Orten-Luiten; André Janse; Rosalie A M Dhonukshe-Rutten; Renger F Witkamp
Journal:  Drugs Aging       Date:  2014-02       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.